Capillary electrophoresis of metal-based drugs

Analytical Biochemistry

Volumn 369, Issue 1, 2007, Pages 1-7

  Timerbaev, Andrei R ^a   Keppler, Bernhard K ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; CHEMISTRY;

CAPILLARY ELECTROPHORESIS;

CISPLATIN; GALLIUM TRIS(8 QUINOLATO)GALLIUM(III); GLUTATHIONE; IMIDAZOLIUM[TETRACHLORO(1H IMIDAZOLE)(S DIMETHYLSULFOXIDE)RUTHENATE(III)]; INDAZOLIUM[TETRACHLOROBIS(1H INDAZOLE)RUTHENATE(III)]; OXALIPLATIN; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

CAPILLARY ELECTROPHORESIS; DRUG BINDING; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG MECHANISM; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERMETHOD COMPARISON; LIPOPHILICITY; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

EID: 34548165203     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.05.009     Document Type: Review

References (28)

1. Hartinger C.G., Timerbaev A.R., and Keppler B.K. Capillary electrophoresis in anti-cancer metallodrug research: Advances and future challenges. Electrophoresis 24 (2003) 2023-2037
2. Kapp T., Dullin A., and Gust R. Mono-, polynuclear [alkylamine]platinum(II) complexes of [1,2-bis(4-fluorophenyl)ethylenediamine]platinum(II): Synthesis and investigations on cytotoxicity cellular distribution and DNA and protein binding. J. Med. Chem. 49 (2006) 1182-1190
3. Timerbaev A.R., Rudnev A.V., Semenova O., Hartinger C.G., and Keppler B.K. Comparative binding of antitumor indazolium [trans-tetrachlorobis(1H-indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresis. Anal. Biochem. 341 (2005) 326-333
4. 4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): Aquation, redox properties, protein binding, and antiproliferative activity. J. Med. Chem. 50 (2007) 2185-2193
5. Rudnev A.V., Foteeva L.S., Kowol C., Berger R., Jakupec M.A., Arion V.B., Timerbaev A.R., and Keppler B.K. Preclinical characterization of anticancer gallium(III) complexes: Solubility, stability, lipophilicity, and binding to serum proteins. J. Inorg. Biochem. 100 (2006) 1819-1826
6. Rappel C., Galanski M., Yasemi A., Habala L., and Keppler B.K. Analysis of anticancer platinum(II) complexes by microemulsion electrokinetic chromatography: Separation of diastereomers and estimation of octanol-water partition coefficients. Electrophoresis 26 (2005) 878-884
7. Timerbaev A.R., Vasylenko O.O., Foteeva L.S., Rudnev A.V., Semenova O., and Keppler B.K. Application of micellar and microemulsion electrokinetic chromatography for characterization of gallium(III) complexes of pharmaceutical significance. J. Sep. Sci. 30 (2007) 399-406
8. Oswałdowski S., and Timerbaev A.R. Development of quantitative structure-activity relationships for interpretation of the migration behavior of neutral platinum(II) complexes in microemulsion electrokinetic chromatography. J. Chromatogr. A 1146 (2007) 258-263
9. Timerbaev A.R., Hartinger C.G., Aleksenko S.S., and Keppler B.K. Interactions of antitumor metallodrugs with serum proteins: Advances in characterization using modern analytical methodology. Chem. Rev. 106 (2006) 2224-2248
10. Warnecke A., Fichtner I., Garmann D., Jaehde U., and Kratz F. Synthesis and biological activity of water-soluble maleimide derivatives of the anticancer drug carboplatin designed as albumin-binding prodrugs. Bioconj. Chem. 15 (2004) 1349-1359
11. Timerbaev A.R., Aleksenko S.S., Polec-Pawlak K., Ruzik R., Semenova O., Hartinger C.G., Oszwaldowski S., Galanski M., Jarosz M., and Keppler B.K. Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: Characterization of interactions between Pt(II) complexes and human serum albumin. Electrophoresis 25 (2004) 1988-1995
12. Polec-Pawlak K., Abramski J.K., Semenova O., Hartinger C.G., Timerbaev A.R., Keppler B.K., and Jarosz M. Platinum group metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: A further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins. Electrophoresis 27 (2006) 1128-1135
13. Hartinger C.G., Hann S., Koellensperger G., Sulyok M., Groessl M., Timerbaev A.R., Rudnev A.V., Stingeder G., and Keppler B.K. Interactions of a novel ruthenium-based anticancer drug (KP1019 or FFC14a) with serum proteins: Significance for the patient. Intl. J. Clin. Pharmacol. Ther. 43 (2005) 583-585
14. A.R. Timerbaev, L.S. Foteeva, A.V. Rudnev, J.K. Abramski, K. Połeć-Pawlak, C.G. Hartinger, M. Jarosz, B.K. Keppler, Probing the stability of serum protein-ruthenium(III) drug adducts in the presence of extracellular reductants using capillary electrophoresis, Electrophoresis (in press).
15. Rudnev A.V., Aleksenko S.S., Semenova O., Hartinger C.G., Timerbaev A.R., and Keppler B.K. Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method. J. Sep. Sci. 28 (2005) 121-127
16. Ahmed-Ouameur A., Diamantoglou S., Sedaghat-Herati M.R., Nafisi S., Carpentier R., and Tajmir-Riahi H.A. The effects of drug complexation on the stability and conformation of human serum albumin: Protein unfolding. Cell Biochem. Biophys. 45 (2006) 203-213
17. S.S. Aleksenko, C.G. Hartinger, O. Semenova, K. Meelich, A.R. Timerbaev, B.K. Keppler, Characterization of interactions between human serum albumin and tumor-inhibiting aminoalcohol platinum(II) complexes using capillary electrophoresis, J. Chromatogr. A (in press).
18. Hartinger C.G., Schluga P., Galanski M., Baumgartner C., Timerbaev A.R., and Keppler B.K. Tumor-inhibiting platinum(II) complexes with aminoalcohol ligands: Comparison of the mode of action by capillary electrophoresis and electrospray ionization-mass spectrometry. Electrophoresis 24 (2003) 2038-2044
19. 2 N,O)platinum(II): A representative of novel pH sensitive anticancer platinum complexes. Inorg. Chim. Acta 357 (2004) 3237-3244
20. Meelich K., Galanski M., Arion V.B., Jakupec M.A., Schluga P., Hartinger C.G., von Keyserlingk N.G., and Keppler B.K. Activation of anticancer platinum complexes by tumoral acidity. Metal Ions Biol. Med. 9 (2006) 52-58
21. Zorbas-Seifried S., Jakupec M.A., Kukushkin N.V., Groessl M., Hartinger C.G., Semenova O., Zorbas H., Kukushkin V.Y., and Keppler B.K. Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands. Mol. Pharmacol. 71 (2007) 357-365
22. I. Berger, A.A. Nazarov, C.G. Hartinger, M. Groessl, B.K. Keppler, Rational development of oxaliplatin analogues: Synthesis and preliminary structure-activity relationships, ChemBioChem., in press.
23. Schluga P., Hartinger C.G., Galanski M., Meelich K., Timerbaev A.R., and Keppler B.K. Tumour-inhibiting platinum(II) complexes with aminoalcohol ligands: Biologically important transformations studied by micellar electrokinetic chromatography, nuclear magnetic resonance spectroscopy, and mass spectrometry. Analyst 130 (2005) 1383-1389
24. Warnke U., Rappel C., Meier H., Kloft C., Galanski M., Hartinger C.G., Keppler B.K., and Jaehde U. Analysis of platinum adducts with DNA nucleotides and nucleosides by capillary electrophoresis coupled to ESI-MS: Indications of guanosine 5′-monophosphate O6-N7 chelation. Chem. Bio. Chem. 5 (2004) 1543-1549
25. Schluga P., Hartinger C.G., Egger A., Reisner E., Galanski M., Jakupec M.A., and Keppler B.K. Redox behavior of tumor-inhibiting ruthenium(III) complexes and effects of physiological reductants on their binding to GMP. Dalton Trans. (2006) 1796-1802
26. - and preparation of a model nucleobase adduct. Metal Ions Biol. Med. 9 (2006) 24-29
27. Ahmed-Ouameur A., Arakawa H., and Tajmir-Riahi H.A. Binding of oxovanadium ions to the major and minor grooves of DNA duplex: Stability and structural models. Biochem. Cell Biol. 84 (2006) 677-683
28. Huang Z., Timerbaev A.R., Keppler B.K., and Hirokawa T. Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques. J. Chromatogr. A 106 (2006) 75-79